U.S. Congressman welcomes India's decision to resume COVID-19 vaccine exports
The Hindu
‘As the world's leading vaccine manufacturer, India's role is critical to defeating this pandemic,’ tweted Gregory Meeks
An influential US Congressman has welcomed India's decision to resume the export of surplus to meet its commitment to the COVAX global pool.
Union Health Minister Mansukh Mandaviya on September 20, 2021 said in the fourth quarter of this year under the 'Vaccine Maitri' programme to meet its commitment to the COVAX global pool.
He, however, asserted that vaccinating own citizens remains the topmost priority of the government. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations and WHO.

Former CM B.S. Yediyurappa had challenged the first information report registered on March 14, 2024, on the alleged incident that occurred on February 2, 2024, the chargesheet filed by the Criminal Investigation Department (CID), and the February 28, 2025, order of taking cognisance of offences afresh by the trial court.